<DOC>
	<DOC>NCT02169349</DOC>
	<brief_summary>The purpose of this study is to develop an ultra sensitive assay of mutation detection on circulating tumor DNA (ctDNA) for treatment, diagnosis and monitoring disease progression of Non-Small Cell Lung Cancer (NSCLC).</brief_summary>
	<brief_title>Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Signed written informed consent Male or female aged &gt;= 18 years Stage IIIb and IV Non Small Cell Lung Cancer histologically confirmed Tissue and plasma samples can not be provided for mutation analysis Unwilling or unable to provide informed consent Any serious medical condition that would interfere with the subject's safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>